Schad, Caroline <br/><br/>
Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Feb 2016 
 - 797-805 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00426-15  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiprotozoal Agents--chemistry<br/>Aziridines--chemistry<br/>Cathepsin B--antagonists & inhibitors<br/>Cysteine Proteinase Inhibitors--chemistry<br/>Leishmania major--drug effects<br/>Leishmaniasis--drug therapy<br/>Papain--antagonists & inhibitors<br/>Th2 Cells--immunology